|国家科技期刊平台
首页|期刊导航|医药导报|医疗机构乳腺癌患者全程药学服务路径

医疗机构乳腺癌患者全程药学服务路径OACSTPCD

Whole Process of Pharmaceutical Service Pathway for Breast Cancer Patients in Medical Institutions

中文摘要英文摘要

目的 制定药学服务路径,规范药师在医疗机构中对乳腺癌患者的全程药学服务,促进药师工作标准化,提高医疗机构中乳腺癌患者用药合理性.方法 编写委员会针对医疗机构乳腺癌患者全程药学服务中的多个难点问题,通过系统检索,参考国内外最新的乳腺癌诊疗指南和专家共识,对照我国相关药事管理规定,收集整理医师、药师以及方法学专家的专业意见,制定问卷,并召开两轮专家论证会,最终筛选出最具价值的资料和结果,制定乳腺癌患者药学服务全程管理路径,并对不同层级医院的转诊原则以及药师培训与考核内容做了阐明.结果 制定乳腺癌患者药学服务全程管理路径,包括信息收集、分析评估、制定和执行干预计划、随访.结论 该药学服务路径可规范和指导不同层级医院的药师开展乳腺癌患者药学服务,实现用药全程监护,保障患者的合理用药和治疗效果.

Objective To formulate a pharmaceutical service pathway to standardize the pharmacists'whole process of pharmaceutical services for breast cancer patients in medical institutions,promote the standardization of pharmacists'work and improve the rationality of drug use for breast cancer patients in medical institutions.Methods The editorial committee aimed at several challenging problems in the whole process of pharmaceutical services for breast cancer patients in medical institutions through systematic search,referring to the latest domestic and international guidelines and expert consensus of breast cancer and under the relevant drug administration regulations in China,collected and sorted out the professional opinions of doctors,pharmacists,and methodological experts,developed questionnaires and held two rounds of expert argumentation meetings,and finally screened out the most valuable results.The whole process management pathway of pharmaceutical care for breast cancer patients was formulated,and the referral principles of hospitals at different levels and the contents of pharmacist training and assessment were clarified.Results The whole process management pathway of pharmaceutical services for breast cancer patients was developed,including information collection,analysis,evaluation,development implementation of intervention plans,and follow-up.Conclusion This pharmaceutical service pathway can standardize and guide pharmacists in hospitals at different levels to carry out pharmaceutical services for breast cancer patients,achieve the whole process of monitoring drug use,and ensure rational drug use and treatment effectiveness for patients.

吕子彦;边原;蔡林璇;童荣生;陈岷

四川省医学科学院·四川省人民医院药学部,成都 610072||电子科技大学医学院个体化药物治疗四川省重点实验室,成都 610072

药学

乳腺癌药学服务药学服务路径

Breast cancerPharmaceutical servicesPharmaceutical service pathway

《医药导报》 2024 (001)

5-12 / 8

国家重点研发计划主动健康和老龄化科技应对重点专项(2020YFC2005500);2021年度个体化药物治疗四川省重点实验室开放和自拟课题资助项目(2021YB10);四川省科技厅重点研发计划(2019YFS0514);个体化药物治疗四川省重点实验室开发课题(2021YB02);四川省干部保健科研课题(川干研2021-238);吴阶平基金会临床科研专项基金资助项目(320.6750.2023-06-26).

10.3870/j.issn.1004-0781.2024.01.002

评论